ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $382 | -47.7% | 34,175 | 0.0% | 0.06% | -46.7% |
| Q2 2023 | $731 | -47.1% | 34,175 | 0.0% | 0.12% | -49.4% |
| Q1 2023 | $1,382 | -17.9% | 34,175 | -5.6% | 0.24% | -23.5% |
| Q4 2022 | $1,684 | -99.9% | 36,205 | 0.0% | 0.31% | -17.6% |
| Q3 2022 | $1,878,000 | -17.4% | 36,205 | -24.7% | 0.38% | -13.8% |
| Q2 2022 | $2,274,000 | -40.1% | 48,110 | -9.8% | 0.44% | -33.0% |
| Q1 2022 | $3,798,000 | -33.1% | 53,360 | -29.7% | 0.65% | -31.2% |
| Q4 2021 | $5,673,000 | +59.4% | 75,869 | +21.1% | 0.95% | +43.8% |
| Q3 2021 | $3,558,000 | – | 62,635 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |